Use of brimonidine for preventing and reducing the severity of stress-associated conditions

Details for Australian Patent Application No. 2010241513 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Donello, John E.; Brin, Mitchell F.; Whitcup, Scott M.

Agent Davies Collison Cave

Pub. Number AU-B-2010241513

Parent 2004253500

Filing date 18 November 2010

Wipo publication date 9 December 2010

Acceptance publication date 22 September 2011

International Classifications

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 December 2010 Complete Application Filed

9 December 2010 Application Open to Public Inspection

  Published as AU-B-2010241513

22 September 2011 Application Accepted

  Published as AU-B-2010241513

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241514-Method and apparatus for processing escrow transactions

2010241512-An extrusion having a security feature